Former ExThera Medical Corporation Executive Admits to Concealing Patient Deaths from FDA and Company Enters Deferred Prosecution Agreement

A former California executive was charged today and has agreed to plead guilty in connection with failing to file adverse event reports with the intent to defraud and mislead the Food and Drug Administration (FDA) in connection with a blood filtration device. used on cancer patients who traveled to Antigua for treatment. A plea hearing has not yet been scheduled by the court.